Table 3.

Triglycerides ¹.

Reference	SIGN Quality	CVD-Related Disease Status	Anthocyanin Dose (mg/Day)	Triglycerides (mg/dL)
				Percent Change in Intervention	Percent Change in Control	Percent Difference Compared with Control	P
Curtis et al., 2009 [26]	H	Healthy	500	11.11	11.11	0.00	NS
Gurrola-Díaz et al., 2010 [15]	A	Healthy	19.24	−8.24	−19.73	11.50	NR
Gurrola-Díaz et al., 2010 [15]	A	MetS	19.24	−37.94	−17.04	−20.91	NS
Hassellund et al., 2013 [18]	A	Prehypertension	640	ND	ND	ND	0.127
Kianbakht et al., 2014 [20]	A	Hyperlipidemic	7.35	−18.67	−9.68	−8.99	0.002
Naruszewicz et al., 2007 [14]	A	Post-MI	64	−6.15	−3.49	−2.66	NS
Qin et al., 2009 [21]	H	Dyslipidemic	320	−4.24	−2.62	−1.62	0.576
Soltani et al., 2014 [22]	H	Hyperlipidemic	90	−30.79	3.76	−34.55	<0.001
Zhu et al., 2013 [24]	A	Hyperlipidemic	320	−4.08	−2.90	−1.18	0.462

¹ Percent change is calculated as follows: (end of study value − baseline value)/(baseline value) × 100. A, acceptable; H, high quality; CVD, cardiovascular disease; MetS, metabolic syndrome; MI, myocardial infarction; ND, not determined; NR, not reported; NS, not significant; SIGN, Scottish Intercollegiate Guidelines Network.